When you donate to the Foundation for the New England Medical Innovation Center, you support innovators and entrepreneurs in Med Tech.

Ultimately, we help usher technologies to market so that they achieve their visions; which include advancing the patient and caregiver experience, creating more environmentally sustainable solutions, improving outcomes, mitigating risks, reducing costs, and much more.

When an infant under four weeks of age shows a fever, the standard of care is a spinal tap to rule out Meningitis. This infection is dangerous, and delays in diagnosis can lead to an extended hospital stay or even death. The traditional constraint method consists of physically holding the baby in a 'crunched' position during the spinal tap procedure, which requires several people to keep the baby perfectly still while the tap is administered.

Lenoss Medical has entered the scene to introduce a disruptive new method of vertebral body augmentation. Lenoss Medical is a start-up with an innovative, biological bone implant technology for the treatment of painful spinal fractures. When natural, biological bone implants are used in weak, fractured vertebrae, a regenerative process can occur: new bone building, and repair of the fractured vertebrae may occur.

Providence, RI – May 5th, 2021 – Lenoss Medical, a biomedical start up focused on physiological repair of osteoporotic spinal fractures has raised $1.3 million in a seed funding round from Cherrystone Angel Group, Slater Technology Fund, Walnut Ventures, Beacon Angels, River Valley Investors, Magpie Neurosurgical Innovation Fund and Mr. Hansjoerg Wyss.

Congratulations to a NEMIC Fellow, Lura Health on being awarded a National Science Foundation (NSF) Phase I SBIR grant for $256,000. This grant will support the development of their current intra-oral salivary pH monitor and help them progress towards the ultimate vision of creating a comprehensive personal health management system, using saliva as a diagnostic medium.

a blog post by Managing Partner, Aidan Petrie

In the years that I have taught innovation and worked with many hundreds of companies, big and small, we hear over and over again that we have to go in search of problems to solve as a route to innovation.

There is some confusion over the EUA guidelines, what they mean for innovators in the MedTech field, how to use them well and what to watch out for. Read the blog for clarity on EUA submissions.

So you have a great idea for a new technology, or even better, you’re already deep into the research and development process. With a little financial backing, your idea could become a reality and change healthcare as we know it. That’s the dream, but there’s a big gap between developing a technology in the lab or clinic, and successfully fundraising for a medical technology startup.

We believe that Med Tech offers a very interesting investment opportunity and methodology. Strangely, the FDA's development process configures that methodology. How so..?